Rationale The risk of recurrence following a stroke or transient ischemic attack is high,
especially immediately after the event. Hypothesis Because two antiplatelet agents are …

Atrial fibrillation (AF) confers increased risk of stroke and other thromboembolic events, and
oral anticoagulation therefore is the essential part of AF management to reduce the risk of …

Previous studies have rarely investigated the role of non-vitamin K oral anticoagulants
(NOAC) and warfarin in the secondary prevention of ischemic stroke patients with …

AF patients with history of thromboembolic events are at higher risk of thromboembolic
recurrences, despite appropriate antithrombotic treatment. We aimed to evaluate the effect of …

It remains unknown whether the comparative effectiveness of direct oral anticoagulants
(DOACs) and warfarin differs between atrial fibrillation patients with and without a history of …

Background: We determined the long-term event incidence among elderly patients with
nonvalvular atrial fibrillation in terms of history of stroke/transient ischemic attack (TIA) and …

Bacterial resistance to antibiotics is an increasing problem in Canada and worldwide. 1-4
Vancomycin-resistant enterococci (VRE) are strains of Enterococcus faecium or …

Рассматриваются основные причины, патогенетические, клинические и
терапевтические аспекты кардиэмболического инсульта (КЭИ). Подчеркивается, что …

Background: Although widely used in clinical fields, real-world data on the role of warfarin
and non-vitamin K oral anticoagulants (NOACs) for the secondary prevention of …

Background Understanding the value of new anticoagulation therapies compared with
existing therapies is of paramount importance in today's cost-conscious and efficiency …